Trial on Pulmonary Artery Catheters in Cardiac Surgery Aims to Compare Recovery Outcomes
If successful, this trial could lead to changes in surgical protocols, affecting device manufacturers and healthcare providers focused on cardiac surgery.
Phase III
Cardiology / Surgical Intervention
Status
Active
Signal Score
6.8
Signal assessment
Signal strength
moderate
Confidence level
moderate
Strategic implication
If successful, this trial could lead to changes in surgical protocols, affecting device manufacturers and healthcare providers focused on cardiac surgery.
Why it matters
If successful, this trial could lead to changes in surgical protocols, affecting device manufacturers and healthcare providers focused on cardiac surgery.
What changed
Trial Update
Analysis
This clinical trial will evaluate the impact of avoiding pulmonary artery catheters on recovery outcomes in cardiac surgery patients.
If successful, this trial could lead to changes in surgical protocols, affecting device manufacturers and healthcare providers focused on cardiac surgery.
Monitor trial results regarding recovery metrics and complication rates, expected in the next 6-12 months.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.